P O Andersson Selected Research

trofosfamide

12/2002

Trofosfamide as salvage therapy for anaplastic large cell lymphoma relapsing after high-dose chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P O Andersson Research Topics

Disease

2	Lymphoma (Lymphomas) 12/2002 - 01/2000
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2002 - 09/2000
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2002
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2002
1	Hemorrhage 08/2002
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2000
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2000
1	Essential Thrombocythemia 01/2000
1	Disease Progression 01/2000

Drug/Important Bio-Agent (IBA)

2	Alkylating AgentsIBA 12/2002 - 01/2000
2	Inosine Triphosphate (ITP)IBA 08/2002 - 09/2000
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2016
1	ibrutinibIBA 12/2016
1	trofosfamideIBA 12/2002
1	AutoantibodiesIBA 09/2000
1	CytokinesIBA 09/2000
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2000

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2002 - 01/2000
1	Palliative Care (Palliative Therapy) 12/2002
1	Salvage Therapy 12/2002
1	Stem Cell Transplantation 01/2000
1	Transplantation 01/2000